ETFs for Hedge Funds’ Favorite Pharma Stocks

Merger mania in the health care sector is on full display Monday after Swiss pharmaceuticals giant Roche announced Sunday it will acquire InterMune (NasdaqGS: ITMN) for $8.3 billion in cash. The news, which has bolstered shares of several biotechnology exchange traded funds that hold shares of...